Clinical Trial Update: Allergic Disease Onset Prevention Study [Phase 1, Phase 2]

View source ↗

Summary

Siolta Therapeutics reports completion of Phase 1 and Phase 2 for the Allergic Disease Onset Prevention Study, investigating prevention strategies in Atopic Der…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Snippet

Sponsor: Siolta Therapeutics, Inc. | Conditions: Atopic Dermatitis, Type 1 Hypersensitivity | Phase 1, Phase 2 | Status: COMPLETED